# IMPRoving Outcomes in Vascular DisEase - Aortic Dissection

> **NCT06087029** · NA · RECRUITING · sponsor: **Duke University** · enrollment: 1100 (estimated)

## Conditions studied

- Type B Aortic Dissection

## Interventions

- **PROCEDURE:** TEVAR
- **OTHER:** Guideline directed medical therapy and surveillance of dissection

## Key facts

- **NCT ID:** NCT06087029
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-14
- **Primary completion:** 2030-06-01
- **Final completion:** 2030-06-30
- **Target enrollment:** 1100 (ESTIMATED)
- **Last updated:** 2026-04-29

## Collaborators

- The University of Texas Health Science Center, Houston
- State University of New York - Downstate Medical Center
- Oregon Health and Science University
- National Heart, Lung, and Blood Institute (NHLBI)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06087029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06087029, "IMPRoving Outcomes in Vascular DisEase - Aortic Dissection". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06087029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*